Walleye Capital LLC Repligen Corp Put Options Transaction History

Walleye Capital LLC

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$119.79 - $167.35 $71,874 - $100,410	600 Added 27.27%	2,800 $416,000
Q2 2024 Aug 14, 2024	BUY	$120.0 - $182.95 $48,000 - $73,180	400 Added 22.22%	2,200 $277,000
Q1 2024 May 15, 2024	SELL	$170.78 - $208.42 $17,078 - $20,842	-100 Reduced 5.26%	1,800 $331,000
Q4 2023 Feb 14, 2024	SELL	$114.17 - $185.35 $730,688 - $1.19 Million	-6,400 Reduced 77.11%	1,900 $341,000
Q3 2023 Nov 14, 2023	BUY	$138.78 - $176.51 $666,144 - $847,248	4,800 Added 137.14%	8,300 $1.32 Million
Q2 2023 Aug 14, 2023	BUY	$138.42 - $180.31 $484,469 - $631,085	3,500 New	3,500 $495,000
Q1 2020 May 15, 2020	SELL	$84.96 - $109.14 $229,391 - $294,678	-2,700 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$73.84 - $93.08 $590,720 - $744,640	-8,000 Reduced 74.77%	2,700 $250,000
Q3 2019 Nov 14, 2019	SELL	$76.65 - $95.51 $720,510 - $897,794	-9,400 Reduced 46.77%	10,700 $821,000
Q2 2019 Aug 14, 2019	BUY	$54.2 - $85.95 $1.08 Million - $1.71 Million	19,900 Added 9950.0%	20,100 $1.73 Million
Q1 2019 May 15, 2019	BUY	$49.45 - $62.8 $9,890 - $12,560	200 New	200 $12,000

489

54.3M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.18B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.